Logo image of MCPHY.PA

MCPHY ENERGY SA (MCPHY.PA) Stock Fundamental Analysis

EPA:MCPHY - Euronext Paris - Matif - FR0011742329 - Common Stock - Currency: EUR

2.32  +0 (+0.22%)

Fundamental Rating

2

MCPHY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Machinery industry. Both the profitability and financial health of MCPHY have multiple concerns. MCPHY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MCPHY has reported negative net income.
In the past year MCPHY has reported a negative cash flow from operations.
MCPHY had negative earnings in each of the past 5 years.
MCPHY had a negative operating cash flow in each of the past 5 years.
MCPHY.PA Yearly Net Income VS EBIT VS OCF VS FCFMCPHY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

MCPHY has a Return On Assets of -28.85%. This is amonst the worse of the industry: MCPHY underperforms 94.50% of its industry peers.
Looking at the Return On Equity, with a value of -53.75%, MCPHY is doing worse than 90.83% of the companies in the same industry.
Industry RankSector Rank
ROA -28.85%
ROE -53.75%
ROIC N/A
ROA(3y)-19.55%
ROA(5y)-16.85%
ROE(3y)-31.9%
ROE(5y)-27.63%
ROIC(3y)N/A
ROIC(5y)N/A
MCPHY.PA Yearly ROA, ROE, ROICMCPHY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

With a Gross Margin value of 14.75%, MCPHY is not doing good in the industry: 90.83% of the companies in the same industry are doing better.
MCPHY's Gross Margin has declined in the last couple of years.
MCPHY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-31.69%
GM growth 5Y-19.17%
MCPHY.PA Yearly Profit, Operating, Gross MarginsMCPHY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

MCPHY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MCPHY remains at a similar level compared to 1 year ago.
The number of shares outstanding for MCPHY has been increased compared to 5 years ago.
The debt/assets ratio for MCPHY is higher compared to a year ago.
MCPHY.PA Yearly Shares OutstandingMCPHY.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MCPHY.PA Yearly Total Debt VS Total AssetsMCPHY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.85, we must say that MCPHY is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MCPHY (-0.85) is worse than 81.65% of its industry peers.
MCPHY has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, MCPHY belongs to the top of the industry, outperforming 90.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.85
ROIC/WACCN/A
WACC7.47%
MCPHY.PA Yearly LT Debt VS Equity VS FCFMCPHY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

MCPHY has a Current Ratio of 1.56. This is a normal value and indicates that MCPHY is financially healthy and should not expect problems in meeting its short term obligations.
MCPHY has a Current ratio (1.56) which is comparable to the rest of the industry.
A Quick Ratio of 1.43 indicates that MCPHY should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.43, MCPHY is doing good in the industry, outperforming 74.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.43
MCPHY.PA Yearly Current Assets VS Current LiabilitesMCPHY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MCPHY have decreased strongly by -24.41% in the last year.
MCPHY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.89%.
MCPHY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.75% yearly.
EPS 1Y (TTM)-24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.49%
Revenue 1Y (TTM)16.89%
Revenue growth 3Y11.09%
Revenue growth 5Y18.75%
Sales Q2Q%8.25%

3.2 Future

Based on estimates for the next years, MCPHY will show a very strong growth in Earnings Per Share. The EPS will grow by 22.79% on average per year.
The Revenue is expected to grow by 51.36% on average over the next years. This is a very strong growth
EPS Next Y-2.53%
EPS Next 2Y8.21%
EPS Next 3Y14.96%
EPS Next 5Y22.79%
Revenue Next Year66.02%
Revenue Next 2Y72.07%
Revenue Next 3Y95.14%
Revenue Next 5Y51.36%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCPHY.PA Yearly Revenue VS EstimatesMCPHY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
MCPHY.PA Yearly EPS VS EstimatesMCPHY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MCPHY. In the last year negative earnings were reported.
Also next year MCPHY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCPHY.PA Price Earnings VS Forward Price EarningsMCPHY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCPHY.PA Per share dataMCPHY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as MCPHY's earnings are expected to grow with 14.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.21%
EPS Next 3Y14.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MCPHY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MCPHY ENERGY SA

EPA:MCPHY (8/8/2024, 7:00:00 PM)

2.32

+0 (+0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-30 2024-07-30
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap67.60M
Analysts41.82
Price Target3 (29.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.96%
PT rev (3m)-39.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.31%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)31.66%
Revenue NY rev (3m)31.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.6
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-1.7
EYN/A
EPS(NY)-1.69
Fwd EYN/A
FCF(TTM)-2.55
FCFYN/A
OCF(TTM)-1.76
OCFYN/A
SpS0.64
BVpS3.03
TBVpS2.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.85%
ROE -53.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.75%
FCFM N/A
ROA(3y)-19.55%
ROA(5y)-16.85%
ROE(3y)-31.9%
ROE(5y)-27.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-31.69%
GM growth 5Y-19.17%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 412.64%
Cap/Sales 121.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.43
Altman-Z -0.85
F-Score3
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)378.1%
Cap/Depr(5y)233.61%
Cap/Sales(3y)63.29%
Cap/Sales(5y)38.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.49%
EPS Next Y-2.53%
EPS Next 2Y8.21%
EPS Next 3Y14.96%
EPS Next 5Y22.79%
Revenue 1Y (TTM)16.89%
Revenue growth 3Y11.09%
Revenue growth 5Y18.75%
Sales Q2Q%8.25%
Revenue Next Year66.02%
Revenue Next 2Y72.07%
Revenue Next 3Y95.14%
Revenue Next 5Y51.36%
EBIT growth 1Y-30.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.4%
EBIT Next 3Y20.22%
EBIT Next 5Y17.79%
FCF growth 1Y-187.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-205.02%
OCF growth 3YN/A
OCF growth 5YN/A